Contract Pharma
CONTRACT PHARMA stands out as the sole global publication dedicated to Bio/Pharma contract services, boasting a verified circulation of 20,026. This publication offers more in-depth editorial content on contract services and outsourcing than any other source. In 2013 alone, we featured over 700 pages of editorial content centered on outsourcing across our nine issues. CONTRACT PHARMA holds the top position in advertising market share for contract services and outsourcing providers within the Pharma and Biopharma sectors.
Outlet metrics
Global
#582903
United States
#335607
Health/Biotechnology and Pharmaceuticals
#321
Articles
-
1 week ago |
contractpharma.com | Tim Wright
Contract development and manufacturing organizations (CDMOs) are no longer behind-the-scenes partners—they’re strategic players shaping the future of drug development. As the pharmaceutical industry navigates increasingly complex science, regulatory pressure, and global uncertainty, CDMOs are being called on to do more: scale fast, innovate constantly, and deliver quality without compromise.
Leading with Precision: Nick Buschur on Driving Growth and Innovation at Woodstock Sterile Solutions
1 week ago |
contractpharma.com | Tim Wright
In this CEO Spotlight, Contract Pharma sits down with Nick Buschur, Chief Executive Officer of Woodstock Sterile Solutions, to discuss the company’s strategic transformation over the past year. Since taking the helm, Buschur has steered Woodstock with a sharp focus on operational excellence, innovation, and customer partnership—all anchored by deep expertise in blow-fill-seal technology.
-
1 week ago |
contractpharma.com | Tim Wright
As pressures on global supply chains increase, pharmaceutical, biotech, and medical device companies are recognizing that supply chain resiliency depends not only on internal strengths, but on the importance of external partnerships that are fully aligned with their goals and expectations. For companies evaluating a Contract Packaging Organization (CPO), it’s no longer enough to assess capacity or capabilities.
-
1 month ago |
contractpharma.com | Kristin Brooks
The World Obesity Federation’s Global Obesity Observatory estimates that 1 billion adults will have obesity by 2030, and more than half of the world’s population1 will live with overweight or obesity levels by 2035. As such, there has been tremendous focus and growth in obesity drug development, with Wegovy (semaglutide) and Zepbound (tirzepatide) becoming household names in recent years.
-
1 month ago |
contractpharma.com | Tim Wright
Welcome to the April issue of Contract Pharma. This month’s edition highlights critical trends and challenges shaping the pharma manufacturing and development landscape, highlighting new regulatory requirements, advances in therapies, and shifts in manufacturing strategies. First, the pharmaceutical industry’s reliance on analytical testing has grown substantially, driven by increasing regulatory demands and the need for improved quality assurance.
Contract Pharma journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://contractpharma.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →